ETC
Exchange Traded Concepts Portfolio holdings
AUM
$7.83B
1-Year Return
24.45%
This Quarter Return
+13.5%
1 Year Return
+24.45%
3 Year Return
+83.69%
5 Year Return
+131.49%
10 Year Return
–
AUM
$7.83B
AUM Growth
+$2.23B
(+40%)
Cap. Flow
+$1.64B
Cap. Flow
% of AUM
20.98%
Top 10 Holdings %
Top 10 Hldgs %
20.17%
Holding
1,510
New
258
Increased
733
Reduced
396
Closed
118
Top Buys
| 1 |
SPDR Portfolio S&P 500 ETF
SPLG
|
$175M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
$130M |
| 3 |
SPDR Portfolio S&P 500 Growth ETF
SPYG
|
$100M |
| 4 |
SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
$94.1M |
| 5 |
WEEK
Roundhill Weekly T-Bill ETF
WEEK
|
$86.3M |
Top Sells
| 1 |
Vanguard Ultra-Short Bond ETF
VUSB
|
$82.5M |
| 2 |
NVIDIA
NVDA
|
$63.2M |
| 3 |
JPMorgan Ultra-Short Income ETF
JPST
|
$62.1M |
| 4 |
Energy Select Sector SPDR Fund
XLE
|
$60.4M |
| 5 |
Tesla
TSLA
|
$53M |
Sector Composition
| 1 | Technology | 16.08% |
| 2 | Energy | 8.44% |
| 3 | Communication Services | 8.07% |
| 4 | Consumer Discretionary | 7.62% |
| 5 | Financials | 6.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Kontoor Brands
KTB
$4.48B
| – | – |
-308
| Closed | -$19.8K |
|
1452
Kura Oncology
KURA
$730M
| – | – |
-17,474
| Closed | -$115K |
|
1453
Kymera Therapeutics
KYMR
$3.12B
| – | – |
-3,693
| Closed | -$101K |
|
1454
Legend Biotech
LEGN
$6.72B
| – | – |
-3,358
| Closed | -$114K |
|
1455
Logitech
LOGI
$15.8B
| – | – |
-214
| Closed | -$18.1K |
|
1456
Open Lending Corp
LPRO
$262M
| – | – |
-77,055
| Closed | -$213K |
|
1457
Lyell Immunopharma
LYEL
$231M
| – | – |
-12,317
| Closed | -$133K |
|
1458
Medifast
MED
$151M
| – | – |
-17,491
| Closed | -$236K |
|
1459
MacroGenics
MGNX
$138M
| – | – |
-58,434
| Closed | -$74.2K |
|
1460
Merus
MRUS
$5.09B
| – | – |
-2,698
| Closed | -$114K |
|
1461
NextDecade
NEXT
$2.71B
| – | – |
-22,540
| Closed | -$175K |
|
1462
NOV
NOV
$4.92B
| – | – |
-18,201
| Closed | -$277K |
|
1463
Nurix Therapeutics
NRIX
$752M
| – | – |
-9,145
| Closed | -$109K |
|
1464
Nuvation Bio
NUVB
$1.36B
| – | – |
-60,951
| Closed | -$107K |
|
1465
Nuvalent
NUVL
$5.95B
| – | – |
-1,654
| Closed | -$117K |
|
1466
Opko Health
OPK
$1.07B
| – | – |
-338,948
| Closed | -$563K |
|
1467
Precigen
PGEN
$1.34B
| – | – |
-71,566
| Closed | -$107K |
|
1468
RAPT Therapeutics
RAPT
$219M
| – | – |
-14,217
| Closed | -$139K |
|
1469
RCM Technologies
RCMT
$203M
| – | – |
-16,566
| Closed | -$258K |
|
1470
Arcus Biosciences
RCUS
$1.27B
| – | – |
-13,922
| Closed | -$109K |
|
1471
Replimune Group
REPL
$485M
| – | – |
-10,814
| Closed | -$105K |
|
1472
Transocean
RIG
$2.9B
| – | – |
-221,615
| Closed | -$703K |
|
1473
Relay Therapeutics
RLAY
$710M
| – | – |
-36,293
| Closed | -$95.1K |
|
1474
Revolution Medicines
RVMD
$7.67B
| – | – |
-3,255
| Closed | -$115K |
|
1475
Recursion Pharmaceuticals
RXRX
$2B
| – | – |
-18,624
| Closed | -$98.5K |
|